3
Announcements
Trials
Browse
Landscape
Status
Terminated
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Lymphoid
1
Endocrine
1
Conditions
Recurrence
1
Lymphoma, B-Cell
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
170
Rituximab
143
Specimen Handling
82
venetoclax
79
fludarabine
79
obinutuzumab
67
Vincristine
67
Doxorubicin
65
Biopsy
64
Prednisone
63
Magnetic Resonance Spectroscopy
63
zanubrutinib
52
Lenalidomide
52
Dexamethasone
48
Cytarabine
43
Methotrexate
42
blinatumomab
40
Immunotherapy, Adoptive
38
acalabrutinib
37
Bendamustine Hydrochloride
37
Etoposide
32
fludarabine phosphate
31
ibrutinib
28
glofitamab
28
polatuzumab vedotin
26
pirtobrutinib
24
orelabrutinib
24
Gemcitabine
23
Injections
21
pembrolizumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Antibodies, Bispecific
×
Lymphoid
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled